Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

27.08.14 | TyraTech expands retailer base in UK

TyraTech has announced deals with further suppliers in the UK for their VaMousse head lice treatment.

24.07.14 | New Tyratech share & UK distribution deal

Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.

05.06.14 | VaMousse now available online across the US

TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.

24.01.14 | Tyratech to sell Vamousse through Walmart

Tyratech have recently announced a deal to sell Vamousse, their preventative head lice treatment product, through Walmart in the US.

07.10.13 | Tyratech discussing US distribution of head lice products

Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.

29.09.14 | New Review of Lice Treatments

A new critical review of head lice treatments covers the latest treatment methods and clinical trial methodology.

04.09.14 | Successful Phase 3 results for Hatchtech Xeglyze trials

Hatchtech Pty Ltd this week announced successful results for its phase 3 trials of Xeglyze™ Lotion, a novel lice and egg treatment.

27.08.14 | Clinical Trial Roundup

A summary of recent clinical trial news.

24.07.14 | Review of egg-removal abilities of commercial products

A new study investigates the ability of commercial head lice products to remove eggs from hair.

16.07.14 | Comparison of topical and oral ivermectin

A recent study has found topical ivermectin to have better lice eradication rates than oral ivermectin.

morenews-ind.png morenews-sci.png
  • Regulatory News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Scientific News
  • Licecomb Engineering
  • Company News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved